These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28762488)

  • 81. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity.
    Fuggetta MP; Lanzilli G; Cottarelli A; Ravagnan G; Cartenì M; De Maria S; Metafora BM; Metafora V; Metafora S
    J Reprod Immunol; 2008 Jul; 78(2):85-93. PubMed ID: 18243331
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays.
    Langhans B; Ahrendt M; Nattermann J; Sauerbruch T; Spengler U
    J Immunol Methods; 2005 Nov; 306(1-2):161-8. PubMed ID: 16202423
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.
    Valiante NM; Trinchieri G
    J Exp Med; 1993 Oct; 178(4):1397-406. PubMed ID: 8376943
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 88. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 90. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
    Speiser DE; Pittet MJ; Valmori D; Dunbar R; Rimoldi D; Liénard D; MacDonald HR; Cerottini JC; Cerundolo V; Romero P
    J Exp Med; 1999 Sep; 190(6):775-82. PubMed ID: 10499916
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells.
    Zimmermann SY; Esser R; Rohrbach E; Klingebiel T; Koehl U
    J Immunol Methods; 2005 Jan; 296(1-2):63-76. PubMed ID: 15680151
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays.
    Chung S; Nguyen V; Lin YL; Kamen L; Song A
    J Immunol Methods; 2017 Aug; 447():37-46. PubMed ID: 28434980
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Modified cytotoxic T lymphocyte precursor frequency assay by measuring released europium in a time resolved fluorometer.
    Haque K; Truman C; Dittmer I; Laundy G; Denning-Kendall P; Hows J; Feest T; Bradley B
    Arch Immunol Ther Exp (Warsz); 1997; 45(1):37-42. PubMed ID: 9090438
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes.
    Harris DT; Jaso-Friedmann L; Evans DL
    Immunol Lett; 1993 Sep; 38(1):11-8. PubMed ID: 8300148
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Relationship between radical production and natural killer cytotoxic factor (NKCF) in canine natural killer (NK) cell-mediated cytotoxicity.
    Nakada Y; Tsukatani Y; Kosaka T; Kuwabara M; Tanaka S; Fujiwara K
    Vet Immunol Immunopathol; 1997 Mar; 55(4):273-82. PubMed ID: 9151399
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.
    Duke RC; Cohen JJ; Chervenak R
    J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates.
    Liu L; Chahroudi A; Silvestri G; Wernett ME; Kaiser WJ; Safrit JT; Komoriya A; Altman JD; Packard BZ; Feinberg MB
    Nat Med; 2002 Feb; 8(2):185-9. PubMed ID: 11821904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.